Clinical Trial Update: Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating liraglutide in obese women with polycystic ovary syndrome has completed. The update confirms the study status but does not i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Polycystic Ovary Syndrome

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Beni-Suef University | Conditions: Polycystic Ovary | Phase 3 | Status: COMPLETED